drug summary · 2 NDC codes
Pradaxa 20 mg/1
dabigatran etexilate
HUMAN PRESCRIPTION DRUG record from the RxAtlas dataset, marketing status NDA. Facts and NDC codes below are exported values from the current release, not inferred or edited prose.
Facts
Field definitions, types, and provenance rules are in the data dictionary.
| generic name | dabigatran etexilate |
|---|---|
| active ingredients | DABIGATRAN ETEXILATE MESYLATE |
| dosage form | PELLET |
| route | ORAL |
| strength | 20 mg/1 |
| marketing status | NDA |
| DEA schedule | not reported |
| application number | NDA214358 |
| ATC code | not reported |
| RxCUI | not reported |
| manufacturer | Boehringer Ingelheim Pharmaceuticals, Inc. |
| product type | HUMAN PRESCRIPTION DRUG |
| pharmacologic class | Direct Thrombin Inhibitor [EPC]; Thrombin Inhibitors [MoA] |
NDC codes
2 National Drug Codes are mapped to this product in the current release. Package descriptions are not part of the published export, so the NDC code is the canonical package identifier here.
| NDC | Package description |
|---|---|
| 00597042578 | — |
| 0597-0425 | — |
Other dabigatran etexilate products
5 other products in the current release publish the same generic name. Strength, dosage form, and labeler are what distinguish them.
- Pradaxa 110 mg/1PELLET · Boehringer Ingelheim Pharmaceuticals, Inc.
- Pradaxa 150 mg/1PELLET · Boehringer Ingelheim Pharmaceuticals, Inc.
- Pradaxa 30 mg/1PELLET · Boehringer Ingelheim Pharmaceuticals, Inc.
- Pradaxa 40 mg/1PELLET · Boehringer Ingelheim Pharmaceuticals, Inc.
- Pradaxa 50 mg/1PELLET · Boehringer Ingelheim Pharmaceuticals, Inc.
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access to the full catalogue; credited toward the licence.